New hope for kids with AML: gentler chemo combos under trial
Disease control
Recruiting now
This early-phase trial is testing two new chemotherapy combinations for children and young adults with acute myeloid leukemia (AML) who are at intermediate or high risk of relapse. The goal is to see if these combinations are tolerable and can achieve similar or better survival w…
Phase: EARLY_PHASE1 • Sponsor: Joanna Yi • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC